Morgan Stanley »

Aim Immunotech shares owned by Morgan Stanley

Quarter-by-quarter ownership of Aim Immunotech (AIM) shares owned by Morgan Stanley from 13F filings

Historical chart of Morgan Stanley investment in Aim Immunotech

Tip: Access up to 7 years of quarterly data

All positions including Aim Immunotech held by Morgan Stanley consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aim Immunotech by Morgan Stanley

Quarter filed Position value Share count Share price at filing
2025-06-30 $6.6k 762 8.65

More positions owned by Morgan Stanley

Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Apple (AAPL)
Amazon (AMZN)
Meta Platforms Cl A (META)
Alphabet Cap Stk Cl A (GOOGL)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Broadcom (AVGO)
JPMorgan Chase & Co. (JPM)
Visa Com Cl A (V)
Ishares Tr Core S&p500 Etf (IVV)
Tesla Motors (TSLA)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Alphabet Cap Stk Cl C (GOOG)

View all positions for Morgan Stanley

Top funds holding Aim Immunotech

DRW Holdings
Sabby Management
Vanguard Group
Geode Capital Management
Morgan Stanley
UBS Group
Community Bank
Pnc Financial Services
Advisor Group Holdings
Hoey Investments
Harbour Investments
Wells Fargo & Company
Steward Partners Investment Advisory
Farther Finance Advisors

View all funds holding Aim Immunotech